Valero earnings skyrocketed in Q1 as refining margins surged. The oil stock reversed higher, after strong rally.

Imugene Limited has applied to the ASX for quotation of 15,077,309 new ordinary fully paid shares, with an issue date of April 24, 2026. The securities form part of a previously announced transaction, ...

On April 28, 2026, Immunic announced the appointment of veteran neurology drug developer Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer, effective April 24, 2026, succeeding co-founder ...

CHC Navigation (CHCNAV), a global provider of geospatial solutions, announced the release of the D60, a dual-frequency single-beam echo sounder engineered for unmanned surface vessel (USV) operations.

Conference Immunic to Participate in Investor and Medical Conferences in May 30.04.2026 / 12:30 CET/CEST The issuer is solely responsible ...